"The U.S. Food and Drug Administration today approved the Impella 2.5 System, a miniature blood pump system intended to help certain patients maintain stable heart function and circulation during certain high-risk percutaneous coronary interventio"...
DOSAGE AND ADMINISTRATION
One tablet should be dissolved under the tongue or in the buccal pouch at the first sign of an acute anginal attack. The dose may be repeated approximately every 5 minutes until relief is obtained. If the pain persists after a total of 3 tablets in a 15-minute period, or if the pain is different than is typically experienced, prompt medical attention is recommended. NITROSTAT may be used prophylactically 5 to 10 minutes prior to engaging in activities that might precipitate an acute attack.
During administration the patient should rest, preferably in the sitting position.
No dosage adjustment is required in patients with renal failure.
NITROSTAT is supplied as white, round, flat-faced tablets in 3 strengths (0.3 mg, 0.4 mg, and 0.6 mg) in bottles containing 100 tablets each, with color-coded labels, and in color-coded Patient Convenience Packages of 4 bottles of 25 tablets each.
0.3 mg: Coded “N” on one side and “3” on the other.
NDC 0071-0417-24—Bottle of 100 tablets
0.4 mg: Coded “N” on one side and “4” on the other.
NDC 0071-0418-13—Convenience Package
NDC 0071-0418-24—Bottle of 100 tablets
0.6 mg: Coded “N” on one side and “6” on the other.
NDC 0071-0419-24—Bottle of 100 tablets
Store at Controlled Room Temperature 20°–25°C (68°–77°F) [see USP].
Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017. Revised: March 2014This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 6/13/2016
Additional Nitrostat Information
Nitrostat - User Reviews
Nitrostat User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.